8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide

C55H59F2N11O9S2 — CID 142572482

IUPAC8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide
SMILESCc1ncsc1-c1ccc([C@@]2(C)NC([C@@H]3C[C@@H](O)CN3C(=O)[C@@H](c3cc(OCCN4CC[C@H](NC(=O)c5cc6c(cc5CS(C)(=O)=O)-c5cn(C)c(=O)c7[nH]cc(c57)CN6c5ncc(F)cc5F)C4)no3)C(C)C)NC2=O)cc1
InChIInChI=1S/C55H59F2N11O9S2/c1-28(2)45(52(71)68-24-36(69)17-42(68)49-62-54(73)55(4,63-49)33-9-7-30(8-10-33)48-29(3)60-27-78-48)43-19-44(64-77-43)76-14-13-66-12-11-35(23-66)61-51(70)37-18-41-38(15-31(37)26-79(6,74)75)39-25-65(5)53(72)47-46(39)32(20-58-47)22-67(41)50-40(57)16-34(56)21-59-50/h7-10,15-16,18-21,25,27-28,35-36,42,45,49,58,63,69H,11-14,17,22-24,26H2,1-6H3,(H,61,70)(H,62,73)/t35-,36+,42-,45+,49?,55+/m0/s1
InChIKeyZHNFFGOHWZBFTR-AMHDDFQSSA-N
MW1120.27 g/mol
LogP5.37
Rot. Bonds15

About 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide

8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide (PubChem CID 142572482) has the molecular formula C55H59F2N11O9S2 and a molecular weight of 1120.27 g/mol. Its IUPAC name is 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide.

Molecular Properties

Compound Name8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide
PubChem CID142572482
Molecular FormulaC55H59F2N11O9S2
Molecular Weight1120.27 g/mol
Exact Mass1119.39
IUPAC Name8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide
SMILESCc1ncsc1-c1ccc([C@@]2(C)NC([C@@H]3C[C@@H](O)CN3C(=O)[C@@H](c3cc(OCCN4CC[C@H](NC(=O)c5cc6c(cc5CS(C)(=O)=O)-c5cn(C)c(=O)c7[nH]cc(c57)CN6c5ncc(F)cc5F)C4)no3)C(C)C)NC2=O)cc1
InChIInChI=1S/C55H59F2N11O9S2/c1-28(2)45(52(71)68-24-36(69)17-42(68)49-62-54(73)55(4,63-49)33-9-7-30(8-10-33)48-29(3)60-27-78-48)43-19-44(64-77-43)76-14-13-66-12-11-35(23-66)61-51(70)37-18-41-38(15-31(37)26-79(6,74)75)39-25-65(5)53(72)47-46(39)32(20-58-47)22-67(41)50-40(57)16-34(56)21-59-50/h7-10,15-16,18-21,25,27-28,35-36,42,45,49,58,63,69H,11-14,17,22-24,26H2,1-6H3,(H,61,70)(H,62,73)/t35-,36+,42-,45+,49?,55+/m0/s1
InChIKeyZHNFFGOHWZBFTR-AMHDDFQSSA-N
XLogP5.37
TPSA250.22 Ų
H-Bond Donors5
H-Bond Acceptors17
Rotatable Bonds15
Heavy Atoms79
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001120.27
LogP ≤ 55.37
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1017

Analyze 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide?
The IUPAC name of 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide (CID 142572482) is 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide.
What is the SMILES notation for 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide?
The canonical SMILES for 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide is Cc1ncsc1-c1ccc([C@@]2(C)NC([C@@H]3C[C@@H](O)CN3C(=O)[C@@H](c3cc(OCCN4CC[C@H](NC(=O)c5cc6c(cc5CS(C)(=O)=O)-c5cn(C)c(=O)c7[nH]cc(c57)CN6c5ncc(F)cc5F)C4)no3)C(C)C)NC2=O)cc1.
What is the InChIKey of 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide?
The InChIKey is ZHNFFGOHWZBFTR-AMHDDFQSSA-N. The full InChI is InChI=1S/C55H59F2N11O9S2/c1-28(2)45(52(71)68-24-36(69)17-42(68)49-62-54(73)55(4,63-49)33-9-7-30(8-10-33)48-29(3)60-27-78-48)43-19-44(64-77-43)76-14-13-66-12-11-35(23-66)61-51(70)37-18-41-38(15-31(37)26-79(6,74)75)39-25-65(5)53(72)47-46(39)32(20-58-47)22-67(41)50-40(57)16-34(56)21-59-50/h7-10,15-16,18-21,25,27-28,35-36,42,45,49,58,63,69H,11-14,17,22-24,26H2,1-6H3,(H,61,70)(H,62,73)/t35-,36+,42-,45+,49?,55+/m0/s1.
What are the key properties of 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide?
8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide has a molecular weight of 1120.27 g/mol, XLogP of 5.37, 15 rotatable bonds, 5 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 8-(3,5-difluoro-2-pyridinyl)-N-[(3S)-1-[2-[[5-[(2R)-1-[(2S,4R)-4-hydroxy-2-[(4R)-4-methyl-4-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-5-oxoimidazolidin-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-1,2-oxazol-3-yl]oxy]ethyl]pyrrolidin-3-yl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide is sourced from PubChem (CID 142572482), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).